Stemtech Corporation

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Stemtech Corp. engages in the development of nutritional supplements. It offers RCM System, stemrelease3, StemFlo, MigraStem, Collet One, OraStem, and OraStem 5-Pack. It operates through the following geographical segments: North America, Latin America, and Asia. The North America segment refers to its subsidiaries in United States and Canada. The Latin America segment includes subsidiaries in Mexico and Ecuador. The Asia segment relates to its subsidiaries in Malaysia and Taiwan. The company was founded on September 4, 2009 and is headquartered in Naples, FL.

MIRAMAR, FL, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced that Professor Dr. Bankole Johnson joins the Stemtech Corporation Life Sciences Advisory Board (LSAB).

STEMTECH CORPORATION ANNOUNCES PROFESSOR DR. BANKOLE JOHNSON JOINS THEIR LIFE SCIENCES ADVISORY BOARD

MIRAMAR, FL, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced that it has issued a Letter of Intent to acquire Life Factor Research , a scientific research and development company.

STEMTECH CORPORATION ANNOUNCES LETTER OF INTENT TO ACQUIRE LIFE FACTOR RESEARCH

MIRAMAR, FL, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced that it has sponsored ADVENT EXPO.

STEMTECH CORPORATION ANNOUNCES SPONSORSHIP OF ADVENT EXPO

MIRAMAR, FL, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB: STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, today announced that OraStem®, Stemtech's all-natural toothpaste, has been trademarked registered in Mexico.

STEMTECH CORPORATION ANNOUNCES ORASTEM TRADEMARK REGISTRATION IN MEXICO AND INTRODUCES NEW TRAVEL SIZE

Florida-based nutraceutical company looks to increase customer engagement and drive sales conversion rates by deploying VERB's powerful interactive video-based sales tools

STEMTECH CORPORATION Partners with VERB in Launching Interactive Video and Livestreaming Sales Enablement Apps to Strengthen Direct Sales Channel

MIRAMAR, FL, July 15, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB:STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, announced today that the Company appointed Network Marketing Hall of Famer Izzy Matos to Founding Independent Business Partner.

STEMTECH CORPORATION ELEVATES NETWORK MARKETING HALL OF FAMER IZZY MATOS TO FOUNDING INDEPENDENT BUSINESS PARTNER

MIRAMAR, FL, July 13, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB:STEK), was notified by OTC Markets at close of business Friday July 8th regarding a certain stock promotion which relates to our company's stock. This press release is made by the Board to publicly comment on this Notice received by OTC Markets.

STEMTECH CORPORATION COMMENTS ON RECENT MARKET ACTIVITY

MIRAMAR, FL, June 28, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB:STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, announced today that the Company increased independent business partner recruiting by 38% for the period from April 1, 2022 through June 20, 2022, as compared to the same period last year. Independent business partners include distributors, customers, wholesale buyers, business builders and VIP Customers.

STEMTECH CORPORATION INCREASES INDEPENDENT BUSINESS PARTNER (IBP) RECRUITING BY 38% DURING RECENT ENROLLMENT PERIOD

MIRAMAR, FL, June 09, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB:STEK), an innovative nutraceutical company and a pioneer in the field of ADVANCELLS stem cell nutrition, announced today that Ana Groenewold, an Independent Business Partner from Mexico, has attained the high rank of Chairman's Club Director in May. This coincided with the GLD RSH 90-Day Promotion period where sales and recruitment reached a record 2022 May.

STEMTECH CORPORATION ANNOUNCES ANA GROENEWOLD ACHIEVES CHAIRMAN'S CLUB DIRECTOR STATUS

MIRAMAR, FL, May 18, 2022 (GLOBE NEWSWIRE) -- Stemtech Corporation (“Stemtech”) (OTCQB:STEK), an innovative nutraceutical company and a pioneer in the field of stem cell nutrition, announced today that the Company has been approved for uplisting to the OTCQB® Venture Market (the OTCQB®), which is operated by OTC Markets Group, Inc.

STEMTECH CORPORATION UPLISTS TO OTCQB

News for Stemtech Corporation Stock (STEK)